lawsone has been researched along with Adenocarcinoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ilyas, S; Saif, MW; Wasif, K | 1 |
| Li, P; Tao, Z; Wang, SB | 1 |
2 other study(ies) available for lawsone and Adenocarcinoma
| Article | Year |
|---|---|
Topical henna ameliorated capecitabine-induced hand-foot syndrome.
Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Capecitabine; Deoxycytidine; Female; Fluorouracil; Hand-Foot Syndrome; Humans; Middle Aged; Naphthoquinones; Pancreatic Neoplasms | 2014 |
Lawsone suppresses azoxymethane mediated colon cancer in rats and reduces proliferation of DLD-1 cells via NF-κB pathway.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents, Phytogenic; Azo Compounds; Carcinogens; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; Dextran Sulfate; Endoscopy; Humans; Intestinal Mucosa; Naphthoquinones; NF-kappa B; Rats; Signal Transduction | 2017 |